아폴로믹스 워런트(APLMW)는 NASDAQ에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $0.02 (-0.55%), 시가총액 $0.04B, 52주 범위 $0.01 ~ $0.03.
Apollomics, Inc., a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways. Its solutions include tumor inhibitors, anti-cancer enhancers, and immune-oncology drugs. Apollomics, Inc. was formerly known as CBT Pharmaceuticals, Inc. and changed its name to Apollomics, Inc. in January 2019. Apollomics, Inc.
아폴로믹스 워런트의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackQuant에서 실시간으로 확인할 수 있습니다.
아폴로믹스 워런트의 현재 주가는 $0.02 (-0.55%)입니다. BlackQuant에서 실시간 시세와 차트를 확인할 수 있습니다.
아폴로믹스 워런트의 시가총액은 약 $0.04B입니다.
Apollomics, Inc., a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to in